On May 29, the U.S. Food and Drug Administration (FDA) announces that injectable drugs used in total parenteral nutrition (TPN) will be imported into the U.S. to help ease shortages. The FDA is allowing Fresenius Kabi USA, LLC, to import trace elements and phosphate injection from its Norway plant. Read more.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.